NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EpiHeart

EpiHeart

Private
HelsinkiHealthcare & Life Scienceshttps://epiheart.com/

Last Round

Early Funding

May 1, 2024

Est. Valuation

$5.6M

Total Funding Raised

$740,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

EpiHeart is a medical device company that provides a Cardiac Micrograft Therapy™ treatment to stimulate cardiac tissue recovery and improve heart function.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

cardiac cell therapyheart failure treatmentautologous cell therapysurgical deviceregenerative medicinecardiac tissue regenerationintraoperative therapyadjuvant therapyheart repaircardiac surgerysurgical consumablesminimal tissue processingCE marked deviceCoronary Artery Bypass GraftingCABGLeft Ventricular Assist DeviceLVAD

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EpiHeart Comparables

Compare EpiHeart with similar companies based on industry and business-model similarity.

EpiHeart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CellProthera
68%
Vericel Corporation
65%
BioCardia Inc
63%

EpiHeart Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 1, 2024
SeedFeb 22, 2021
AcceleratorJun 8, 2020

EpiHeart Investors

Notable investors and investment history

EpiHeart investors
InvestorRounds
SPARK FinlandAccelerator
Health Incubator HelsinkiAccelerator, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 885% MoM, reaching 1.6K.

  • Jan 20, 2026

    Monthly visitors grew 962% MoM, reaching 913.

EpiHeart Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EpiHeart Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EpiHeart's valuation, stock price, and market status.

Firmographic Details

HeadquartersHelsinki
Employee Range4
Year Founded2019
Last FundingMay 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.